Inhibitory effect of hydroxyindoles and their analogues on human melanoma tyrosinase

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 65, Issue 1-2, 2010, Pages 54-49

  Yamazaki, Yoshimitsu ^a   Kawano, Yasuhiro ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Hydroxyindole; Inhibitor; Tyrosinase

Indexed keywords

4 HYDROXYINDOLE; 4-HYDROXYINDOLE; 5 HYDROXYINDOLE; 5-HYDROXYINDOLE; 7 HYDROXYINDOLE; 7-HYDROXYINDOLE; INDOLE DERIVATIVE; MONOPHENOL MONOOXYGENASE;

ARTICLE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; HUMAN; HYDROXYLATION; KINETICS; MELANOMA; METABOLISM; PATHOLOGY;

CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROXYLATION; INDOLES; KINETICS; MELANOMA; MONOPHENOL MONOOXYGENASE;

EID: 85044709248     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2010-1-209     Document Type: Article

References (18)

1. Bouchard B., Fuller B., Vijayasaradhi S., and Houghton A. N. (1989), Induction of pigmentation in mouse fi-broblasts by expression of human tyrosinase cDNA. J. Exp. Med. 169, 2029-2042.
2. Cabanes J., García-Carmona F., García-Cánovas F., Iborra J. L., and Lozano J. A. (1984), Kinetic study on the slow inhibition of epidermis tyrosinase by m-cou-maric acid. Biochim. Biophys. Acta 790, 101-107.
3. Chang T.-S. (2009), An updated review of tyrosinase inhibitors. Int. J. Mol. Sci. 10, 2440-2475.
4. Cho S. J., Roh J. S., Sun W. S., Kim S. H., and Park K. D. (2006), V-Benzylbenzamides: a new class of potent tyrosinase inhibitors. Bioorg. Med. Chem. Lett. 16, 2682-2684.
5. Cotteret J. and Audousset M. P. (1993), Oxidative hair dye comprising 2-substituted p-aminophenols com bined with 6- or 7-hydroxyindole. PCT Int. Appl. WO 9320794; Chem. Abstr. 120, 14639.
6. Khan M. T. H. (2007), Molecular design of tyrosinase inhibitors: a critical review of promising novel inhibitors from synthetic origins. Pure Appl. Chem. 79, 2277-2295.
7. Kim Y. M., Yun J., Lee C.-K., Lee H., Min K. R., and Kim Y. (2002), Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action. J. Biol. Chem. 277, 16340-16344.
8. Kubo I., Kinst-Hori I., Chaudhuri S. K., Kubo Y., Sánchez Y., and Ogura T. (2000), Flavonols from Heterotheca inuloides: tyrosinase inhibitory activity and structural criteria. Bioorg. Med. Chem. 8, 1749-1755.
9. Kubo I., Chen Q. X., Nihei K.-I., Calderón J. S., and Céspedes C. L. (2003), Tyrosinase inhibition kinetics of anisic acid. Z. Naturforsch. 58c, 713-718.
10. Liu S.-H., Pan I.-H., and Chu I.-M. (2007), Inhibitory effect of p-hydroxybenzyl alcohol on tyrosinase activity and melanogenesis. Biol. Pharm. Bull. 30, 1135-1139.
11. Muñoz-Muñoz J. L., García-Molina F., García-Ruiz P. A., Molina-Alarcón M., Tudela J., García-Cánovas F., and Rodríguez López J. N. (2008), Phenolic substrates and suicide inactivation of tyrosinase: kinetics and mechanism. Biochem. J. 416, 431-440.
12. Nishida J., Gao H., and Kawabata J. (2007), Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors. Bioorg. Med. Chem. 15, 2396-2402.
13. Okombi S., Rival D., Bonnet S., Mariotte A.-M., Per-rier E., and Boumendjel A. (2006), Analogues of N-hydroxycinnamoylphenalkylamides as inhibitors of human melanocyte-tyrosinase. Bioorg. Med. Chem. Lett. 16, 2252-2255.
14. Perrin D. D. (1979), IUPAC Chemical Data Series No. 22, Stability Constants of Metal-Ion Complexes Part B: Organic Ligands. Pergamon Press, Oxford, pp. 649-651.
15. Pomerantz S. H. (1963), Separation, purification, and properties of two tyrosinases from hamster melanoma. J. Biol. Chem. 238, 23510-2357.
16. Seiji M. (1961), Isolation and properties of tyrosinases from melanomas of Swiss white and C-57 black mice. Federation Proc. 20, 6.
17. Tamura S., Nitoda T., and Kubo I. (2007), Effects of salicylic acid on mushroom tyrosinase and B16 melanoma cells. Z. Naturforsch. 62c, 227-233.
18. Yamazaki Y., Kawano Y., Yamanaka A., and Maruyama S. (2009), N -[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells. Bioorg. Med. Chem. Lett. 19, 4178-4182.